Kleenex Tissue Maker Kimberly-Clark Strikes $48.7 Billion Deal For Tylenol Maker Kenvue

Reuters

Nov 20

Nov 3 (Reuters) - Kimberly-Clark and Kenvue::
*KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER
*KIMBERLY-CLARK CORP: TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2.1 BILLION; EXPECTED TO BE ACCRETIVE TO KIMBERLY-CLARK'S ADJUSTED EPS BY YEAR 2
*KENVUE INC - SHAREHOLDERS TO RECEIVE $3.50 CASH AND 0.14625 KMB SHARES
*KENVUE INC - KIMBERLY-CLARK TO BUY KENVUE AT $48.7 BILLION ENTERPRISE VALUE
*KENVUE: MIKE HSU WILL BE THE CHAIRMAN AND CEO OF THE COMBINED COMPANY
*KENVUE INC: TOTAL CONSIDERATION TO KENVUE SHAREHOLDERS OF $21.01 PER SHARE ON KIMBERLY-CLARK DEAL

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 03-NOV-202511:30:00.467 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2584925355"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2584925355\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2584925355?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 00:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584925355","market":"nz","top_or_hot":-1,"title":"Kleenex Tissue Maker Kimberly-Clark Strikes $48.7 Billion Deal For Tylenol Maker Kenvue","media":"Reuters","content":"<html><body>Nov 3 (Reuters) - Kimberly-Clark and Kenvue::<br/>*KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER<br/>*KIMBERLY-CLARK CORP: TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2.1 BILLION; EXPECTED TO BE ACCRETIVE TO KIMBERLY-CLARK'S ADJUSTED EPS BY YEAR 2<br/>*KENVUE INC - SHAREHOLDERS TO RECEIVE $3.50 CASH AND 0.14625 KMB SHARES<br/>*KENVUE INC - KIMBERLY-CLARK TO BUY KENVUE AT $48.7 BILLION ENTERPRISE VALUE<br/>*KENVUE: MIKE HSU WILL BE THE CHAIRMAN AND CEO OF THE COMBINED COMPANY<br/>*KENVUE INC:  TOTAL CONSIDERATION TO KENVUE SHAREHOLDERS OF $21.01 PER SHARE ON KIMBERLY-CLARK DEAL<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 03-NOV-202511:30:00.467 GMT</body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kleenex Tissue Maker Kimberly-Clark Strikes $48.7 Billion Deal For Tylenol Maker Kenvue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKleenex Tissue Maker Kimberly-Clark Strikes $48.7 Billion Deal For Tylenol Maker Kenvue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-20 00:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Nov 3 (Reuters) - Kimberly-Clark and Kenvue::<br/>*KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER<br/>*KIMBERLY-CLARK CORP: TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2.1 BILLION; EXPECTED TO BE ACCRETIVE TO KIMBERLY-CLARK'S ADJUSTED EPS BY YEAR 2<br/>*KENVUE INC - SHAREHOLDERS TO RECEIVE $3.50 CASH AND 0.14625 KMB SHARES<br/>*KENVUE INC - KIMBERLY-CLARK TO BUY KENVUE AT $48.7 BILLION ENTERPRISE VALUE<br/>*KENVUE: MIKE HSU WILL BE THE CHAIRMAN AND CEO OF THE COMBINED COMPANY<br/>*KENVUE INC:  TOTAL CONSIDERATION TO KENVUE SHAREHOLDERS OF $21.01 PER SHARE ON KIMBERLY-CLARK DEAL<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 03-NOV-202511:30:00.467 GMT</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1571399168.USD","symbol_name":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2NJW7m:1","article_id":"2584925355","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584925355","pubTimestamp":1763569537,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nov 3 (Reuters) - Kimberly-Clark and Kenvue::*KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER*KIMBERLY-CLARK CORP: TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","BK4504":"桥水持仓","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4183":"个人用品","BK4588":"碎股","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","BK4018":"居家用品","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","KMB":"金佰利","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","KVUE":"Kenvue Inc"},"translate_title":"面巾纸制造商Kimberly-Clark以487亿美元收购泰诺制造商Kenvue","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KVUE":0.9,"KMB":0.9},"content_text":"Nov 3 (Reuters) - Kimberly-Clark and Kenvue::*KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER*KIMBERLY-CLARK CORP: TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2.1 BILLION; EXPECTED TO BE ACCRETIVE TO KIMBERLY-CLARK'S ADJUSTED EPS BY YEAR 2*KENVUE INC - SHAREHOLDERS TO RECEIVE $3.50 CASH AND 0.14625 KMB SHARES*KENVUE INC - KIMBERLY-CLARK TO BUY KENVUE AT $48.7 BILLION ENTERPRISE VALUE*KENVUE: MIKE HSU WILL BE THE CHAIRMAN AND CEO OF THE COMBINED COMPANY*KENVUE INC:  TOTAL CONSIDERATION TO KENVUE SHAREHOLDERS OF $21.01 PER SHARE ON KIMBERLY-CLARK DEAL  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 03-NOV-202511:30:00.467 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"executive,corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}